Eye health: Lutein and zeaxanthin could help EU save billions in healthcare costs

ad277b89-9fd7-47a8-850e-d8d9f837437earticleimage.jpg

13 Oct 2017 --- Savings of €6.20 billion (US$7.33 billion) a year could be generated through the daily consumption of 10mg of lutein in combination with 2mg of zeaxanthin by adults aged 50 and older in the EU with age-related macular degeneration (AMD). This is according to a new study produced by Frost & Sullivan.

AMD is a progressive degenerative eye disease and a major cause of vision loss among older Europeans. AMD inhibits the ability to see objects directly ahead and can cause a progressive decline in an individual's independence and ability to perform daily activities. Across the EU, 17.1 million people are living with AMD and numbers are expected to increase by over 30 percent until 2040. Around 2.5 million of these 17.1 million cases are the more costly severe/late stage AMD. The study found that the lutein zeaxanthin combination may reduce the risk of a transition from mild to severe/late stage AMD by 7 percent. 

Frost & Sullivan has calculated that the total cost of managing the consequences of severe/late-stage AMD in the EU is expected to be €89.46 billion per year. This includes the direct costs of treating and managing AMD and the indirect costs related to long-term care. This translates to an annual cost of a transition from mild to severe AMD of € 34,805 per transition in the EU.

“Following an analysis of the available science, Frost & Sullivan's research team concluded that consumption of 10mg of lutein and 2mg of zeaxanthin a day by EU adults aged 50 and older with mild AMD would cut their risk of experiencing a transition to the more severe and costly late stage AMD by 7 percent,” says Christopher J. Shanahan, Global Director at Frost & Sullivan.

Click to Enlarge“Principally, it is increasingly difficult to ignore the fact that supplementation can play a critical role in the future of how healthcare in the EU is funded, resourced and delivered,” Shanahan stated.

Lutein and Zeaxanthin have become of growing interest over the past five years from a product development perspective. According to Innova Market Insights data, new product launches (including supplements) tracked featuring lutein and zeaxanthin saw a compound annual growth rate (CAGR) of +25 percent and +17.7 percent, respectively, between 2012 and 2016, when 2012 is taken as a base of 100.*

The release of the full analysis of the findings on the benefits of using lutein and zeaxanthin food supplements will coincide with a webinar on 2 November, with experts from Frost & Sullivan, BASF, Kemin, DSM, University Hospital of Bordeaux and the University Medical Center Groningen (UMCG).

Speaking on the findings, Julia Raquet, Vice President BASF Human Nutrition Europe, says: “We are impressed with the potential economic advantages presented in this study. The analysis provides consumers and the healthcare industry with valuable insights on the beneficial use of food supplements to maintain eye health for a good quality of life.” 

*Base of 100 for both lutein and zeaxanthin, but start product launch numbers differ for both.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

A personal nutrition touch: A key theme at Vitafoods Europe 2018 

22 May 2018 --- Personalized nutrition has become somewhat of a buzzword in the industry over the past year. But despite its popularity, the term “personalized nutrition” is open to many different interpretations, raising the question of how it is actually to be applied in the industry, with experts pointing to the role of wearable devices, mobile apps and forward-looking options such as genetic profiling. At Vitafoods Europe, NutritionInsight spoke with a number of suppliers about their R&D and views on personalized nutrition.    

Nutrition & Health News

Protein provides benefit for adult bone and joint health, expert consensus reports

17 May 2018 --- Dietary protein intake above the recommended levels may help reduce bone loss and fracture risk in seniors with osteoporosis, an expert consensus reports. Based on an analysis of major research studies, the review, published in Osteoporosis International, found that a protein-rich diet is beneficial for adult bone health. The consensus debunks the popular myth that too much protein may be damaging to bone health.

Nutrition & Health News

DSM announces 4-month summer shutdown to upgrade China vitamin C facility

03 May 2018 --- DSM is to shut down its vitamin C facility in Jiangshan, China, to implement an extensive series of upgrades aimed at improving quality, safety, sustainability and production efficiencies at the site. The prolonged shutdown will start in July and is expected to take four months. DSM has assured the security of supply of vitamin C to its contracted customers during the shutdown.

Nutrition & Health News

Bone and joint health: Consumer demands and promising ingredients

19 Apr 2018 --- Mobility, which incorporates bone and joint health, is becoming a key concern for a range of demographics. NutritionInsight spoke with a number of key suppliers in the bone and joint health space about the key ingredients to look out for, as well as some key consumer demands driving innovation in this space.

Nutrition & Health News

Plant-based possibilities: Report details novel sugar replacements for beverages

19 Apr 2018 --- PreScouter, a Chicago based technology scouting company, details novel replacements for sugars in a new analysis, that are from natural sources, safe, technologically viable and environmentally stable, for use in beverages. The company hopes that the report answers consumer calls for sweeteners that are both natural and healthy, in light of diabetes and obesity epidemics, and that it may aid informing beverage providers on how to best respond to calls for lowering sugar levels in drinks.

More Articles
URL : http://www.nutritioninsight.com:80/news/eye-health-lutein-and-zeaxanthin-could-help-eu-save-billions-in-healthcare-costs.html